Seeking Alpha
Research analyst, long/short equity, ETF investing, foreign companies
Profile| Send Message|
( followers)  
Excerpt from our Wall Street Breakfast, a one-page summary of this morning's key market-moving and stock-moving stories:

Wal-Mart to Expand Discount Drug Plan [New York Times]

Summary: Wal-Mart is expected to announce today that it will expand its discount generic drug plan ahead of its original plan to do so in January, due to strong demand. Its program was introduced in Florida, and will be extended to more than 12 additional states including: New York, Texas, Oregon, Arizona, Vermont and North Carolina. Consumers can purchase month-long doses of 150 different medicines for $4, compared to the average cost of generics of $10-$30.
Related links: Wal-Mart's Cheap Drugs Not as Threatening as they AppearWalgreen Claims No Threat From Wal-Mart's Low Price Generic Drugs • Wal-Mart's Low Cost Generic Drug Implications for Pharmacy Benefit Managers, on Retailers, and on a Macro OutlookWhy Wal-Mart's Drug Program Shouldn't Worry Walgreen and CVS Investors
Potentially impacted stocks and ETFs: Wal-Mart (NYSE:WMT), Walgreen (NYSE:WAG), CVS (NYSE:CVS), Longs Drug Stores (LDG), Rite Aid (NYSE:RAD) • Teva Pharma (NYSE:TEVA), largest seller of generics in U.S. • Pharmacy benefit managers: Medco Health Solutions (NYSE:MHS), Express Scripts (NASDAQ:ESRX) and Caremark (CMX) • Retail HOLDRs ETF (NYSEARCA:RTH)

Seeking Alpha's Wall Street Breakfast summarizes today's key market- and stock-moving news. Receive it by email every weekday morning (free/no spam).

Seeking Alpha is not affiliated with New York Times.

Comment on this article

Source: Wal-Mart Cites Strong Demand, Expanding Discount Drug Program Ahead of Schedule